146 related articles for article (PubMed ID: 33886682)
21. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
[TBL] [Abstract][Full Text] [Related]
22. Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.
Jeon MS; Song SH; Yun J; Kang JY; Kim HP; Han SW; Kim TY
Cancer Res Treat; 2016 Apr; 48(2):676-86. PubMed ID: 26511811
[TBL] [Abstract][Full Text] [Related]
23. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
24. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
[TBL] [Abstract][Full Text] [Related]
25. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
28. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
[TBL] [Abstract][Full Text] [Related]
29. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation Status of E-Cadherin Gene in Gastric Cancer Patients in a High Incidence Area.
Rashid H; Alam K; Afroze D; Yousuf A; Banday M; Kawoosa F
Asian Pac J Cancer Prev; 2016; 17(6):2757-60. PubMed ID: 27356686
[TBL] [Abstract][Full Text] [Related]
31. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
33. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
34. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.
To KF; Leung WK; Lee TL; Yu J; Tong JH; Chan MW; Ng EK; Chung SC; Sung JJ
Int J Cancer; 2002 Dec; 102(6):623-8. PubMed ID: 12448005
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
37. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
38. [Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines].
Yu LF; Zhu YB; Qiao MM; Zhong J; Tu SP; Wu YL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2064-9. PubMed ID: 15730617
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
40. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
